Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Autores de IIS La Fe

• Esperanza Such Taboada

  Autor

• Juan Cervera Deval

  Autor

• Maria José Calasanz Abinzano

  Autor

• Francisco Carbonell

  Autor

• José Bueno Lledó

  Autor

• Fuencisla Ramos Fortea

  Autor

• 

  María Ángeles Tormo Mas

  Autor

• Santiago Bonanad Boix

  Autor

• Guillermo Sanz Santillana

  Autor

Participantes ajenos a IIS La Fe

• Costa D
• Solé F
• Vallespí T
• Luño E
• Collado R
• Hernández-Rivas JM
• Cigudosa JC
• Nomdedeu B
• Mallo M
• Ardanaz MT
• Sancho-Tello R
• del Cañizo C
• Gómez V
• Marco V
• Xicoy B
• Pedro C
• Bernal T

Grupos

• Hematología y Hemoterapia

Abstract

The prognostic value of cytogenetic findings in chronic myelomonocytic leukemia is unclear. Our purpose was to evaluate the independent prognostic impact of cytogenetic abnormalities in a large series of patients with chronic myelomonocytic leukemia included in the database of the Spanish Registry of Myelodysplastic Syndromes.